Acetoacetate accelerates muscle regeneration and ameliorates muscular dystrophy in mice

Journal of Biological Chemistry

Volumn 291, Issue 5, 2016, Pages 2181-2195

  Zou, Xiaoting ^a   Meng, Jiao ^a   Li, Li ^a   Han, Wanhong ^a   Li, Changyin ^a   Zhong, Ran ^a   Miao, Xuexia ^b   Cai, Jun ^b   Zhang, Yong ^a   Zhu, Dahai ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CELLS; CYTOLOGY; KETONES; MAMMALS; METABOLITES; MUSCLE;

CELLULAR ACTIVITIES; MAMMALIAN CELLS; METABOLIC ROLES; MULTIPARAMETER ANALYSIS; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NOVEL FUNCTIONS; SIGNALING MOLECULES;

CELL SIGNALING;

ACETOACETIC ACID; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; RAS PROTEIN; ACETOACETIC ACID DERIVATIVE; KETONE BODY; MAP2K1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MUSCULAR DYSTROPHY, ANIMAL; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ACETOACETATES; ANIMALS; CELL PROLIFERATION; CYCLIN D1; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; KETONE BODIES; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION;

EID: 84957022178     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.676510     Document Type: Article

References (87)

1. Mohanty, S., Singhal, R., Sood, S., Dhawan, B., Das, B. K., and Kapil, A. (2005) Comparative in vitro activity of β-lactam/β-lactamase inhibitor combinations against Gram negative bacteria. Indian J. Med. Res. 122, 425-428
2. Wang, Y. X., and Rudnicki, M. A. (2012) Satellite cells, the engines of muscle repair. Nat. Rev. Mol. Cell Biol. 13, 127-133
3. Braun, T., and Gautel, M. (2011) Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat. Rev. Mol. Cell Biol. 12, 349-361
4. Wagers, A. J., and Conboy, I. M. (2005) Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122, 659-667
5. Kuang, S., Gillespie, M. A., and Rudnicki, M. A. (2008) Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2, 22-31
6. Kamrava, M., Simpkins, F., Alejandro, E., Michener, C., Meltzer, E., and Kohn, E. C. (2005) Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer. Oncogene 24, 7084-7093
7. Usas, A., Mačiulaitis, J., Mačiulaitis, R., Jakuboniene, N., Milašius, A., and Huard, J. (2011) Skeletal muscle-derived stem cells: implications for cellmediated therapies. Medicina 47, 469-479
8. Bhagavati, S. (2008) Stem cell based therapy for skeletal muscle diseases. Curr. Stem Cell Res. Ther. 3, 219-228
9. Endo, T. (2007) Stem cells and plasticity of skeletal muscle cell differentiation: potential application to cell therapy for degenerative muscular diseases. Regen. Med. 2, 243-256
10. Shi, X., and Garry, D. J. (2006) Muscle stem cells in development, regeneration, and disease. Genes Dev. 20, 1692-1708
11. Zeng, L., Akasaki, Y., Sato, K., Ouchi, N., Izumiya, Y., and Walsh, K. (2010) Insulin-like 6 is induced by muscle injury and functions as a regenerative factor. J. Biol. Chem. 285, 36060-36069
12. Cantini, M., Massimino, M. L., Rapizzi, E., Rossini, K., Catani, C., Dalla Libera, L., and Carraro, U. (1995) Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. Biochem. Biophys. Res. Commun. 216, 49-53
13. Riuzzi, F., Sorci, G., Sagheddu, R., and Donato, R. (2012) HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-MAPK-and myogenin-dependent repression of Pax7 transcription. J. Cell Sci. 125, 1440-1454
14. Buchakjian, M. R., and Kornbluth, S. (2010) The engine driving the ship: metabolic steering of cell proliferation and death. Nat. Rev. Mol. Cell Biol. 11, 715-727
15. Ward, P. S., and Thompson, C. B. (2012) Signaling in control of cell growth and metabolism. Cold Spring Harb. Perspect. Biol. 4, a006783
16. Pollard, P. J., and Ratcliffe, P. J. (2009) Cancer. Puzzling patterns of predisposition. Science 324, 192-194
17. Bardella, C., El-Bahrawy, M., Frizzell, N., Adam, J., Ternette, N., Hatipoglu, E., Howarth, K., O'Flaherty, L., Roberts, I., Turner, G., Taylor, J., Giaslakiotis, K., Macaulay, V. M., Harris, A. L., Chandra, A., et al. (2011) Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J. Pathol. 225, 4-11
18. Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., Harris, I. S., Holmes, R., Wakeham, A., Haight, J., You-Ten, A., Li, W. Y., Schalm, S., Su, S. M., Virtanen, C., Reifenberger, G., et al. (2012) IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488, 656-659
19. Yang, M., Soga, T., Pollard, P. J., and Adam, J. (2012) The emerging role of fumarate as an oncometabolite. Front. Oncol. 2, 85
20. Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., Marks, K. M., Prins, R. M., Ward, P. S., Yen, K. E., Liau, L. M., et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744
21. Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., Ding, J., Lei, Q., Guan, K. L., and Xiong, Y. (2009) Gliomaderived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α. Science 324, 261-265
22. Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., Dang, L., Fantin, V. R., and Mak, T. W. (2010) Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J. Exp. Med. 207, 339-344
23. Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., Rabinowitz, J. D., Carroll, M., Su, S. M., Sharp, K. A., Levine, R. L., and Thompson, C. B. (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225-234
24. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian, Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54
25. Yu, F., White, S. B., Zhao, Q., and Lee, F. S. (2001) HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U.S.A. 98, 9630-9635
26. Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y. L., Merino, M., Trepel, J., Zbar, B., Toro, J., Ratcliffe, P. J., Linehan, W. M., and Neckers, L. (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143-153
27. Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., and Gottlieb, E. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77-85
28. Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., van der Mey, A., Taschner, P. E., Rubinstein, W. S., Myers, E. N., Richard, C. W., 3rd, Cornelisse, C. J., Devilee, P., and Devlin, B. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848-851
29. Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G., Eng, C., Latif, F., and Maher, E. R. (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357, 1181-1182
30. Hao, H. X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J. P., Kunst, H., Devilee, P., Cremers, C. W., Schiffman, J. D., Bentz, B. G., Gygi, S. P., Winge, D. R., Kremer, H., and Rutter, J. (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325, 1139-1142
31. Kaelin, W. G., Jr. (2009) SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling. Cancer Cell 16, 180-182
32. Bayley, J. P., Kunst, H. P., Cascon, A., Sampietro, M. L., Gaal, J., Korpershoek, E., Hinojar-Gutierrez, A., Timmers, H. J., Hoefsloot, L. H., Hermsen, M. A., Suárez, C., Hussain, A. K., Vriends, A. H., Hes, F. J., Jansen, J. C., et al. (2010) SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 11, 366-372
33. Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S. H., Ito, S., Yang, C., Xiao, M. T., Liu, L. X., Jiang, W. Q., Liu, J., Zhang, J. Y., Wang, B., Frye, S., et al. (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17-30
34. Oermann, E. K., Wu, J., Guan, K. L., and Xiong, Y. (2012) Alterations of metabolic genes and metabolites in cancer. Semin. Cell Dev. Biol. 23, 370-380
35. King, A., Selak, M. A., and Gottlieb, E. (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25, 4675-4682
36. Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., Zhao, S., Ye, D., Xiong, Y., and Guan, K. L. (2012) Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326-1338
37. Menendez, J. A., and Lupu, R. (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763-777
38. Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C., and Thompson, C. B. (2005) ATP citrate lyase is an important component of cell growth and transformation. Oncogene 24, 6314-6322
39. Minetti, G. C., Feige, J. N., Rosenstiel, A., Bombard, F., Meier, V., Werner, A., Bassilana, F., Sailer, A. W., Kahle, P., Lambert, C., Glass, D. J., and Fornaro, M. (2011) Gαi2 signaling promotes skeletal muscle hypertrophy, myoblast differentiation, and muscle regeneration. Sci. Signal. 4, ra80
40. Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., Wellen, K. E., O'Rourke, D. M., Berger, S. L., Chan, T. A., Levine, R. L., et al. (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474-478
41. Robinson, A. M., and Williamson, D. H. (1980) Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol. Rev. 60, 143-187
42. Macdonald, M. J., Hasan, N. M., and Longacre, M. J. (2008) Studies with leucine, β-hydroxybutyrate and ATP citrate lyase-deficient beta cells support the acetoacetate pathway of insulin secretion. Biochim. Biophys. Acta 1780, 966-972
43. Schönfeld, P., Wieckowski, M. R., Lebiedzińska, M., and Wojtczak, L. (2010) Mitochondrial fatty acid oxidation and oxidative stress: lack of reverse electron transfer-associated production of reactive oxygen species. Biochim. Biophys. Acta 1797, 929-938
44. Samartsev, V. N., and Kozhina, O. V. (2010) Acetoacetate as regulator of palmitic acid-induced uncoupling involving liver mitochondrial ADP/ATP antiporter and aspartate/glutamate antiporter. Biochemistry 75, 598-605
45. Abdelmegeed, M. A., Kim, S. K., Woodcroft, K. J., and Novak, R. F. (2004) Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J. Pharmacol. Exp. Ther. 310, 728-736
46. Jain, S. K., and McVie, R. (1999) Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48, 1850-1855
47. Finn, P. F., and Dice, J. F. (2005) Ketone bodies stimulate chaperonemediated autophagy. J. Biol. Chem. 280, 25864-25870
48. Uehara, Y., Engel, T., Li, Z., Goepfert, C., Rust, S., Zhou, X., Langer, C., Schachtrup, C., Wiekowski, J., Lorkowski, S., Assmann, G., and von Eckardstein, A. (2002) Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 51, 2922-2928
49. Jain, S. K., Kannan, K., Lim, G., Matthews-Greer, J., McVie, R., and Bocchini, J. A., Jr. (2003) Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26, 2139-2143
50. Noh, H. S., Hah, Y. S., Nilufar, R., Han, J., Bong, J. H., Kang, S. S., Cho, G. J., and Choi, W. S. (2006) Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J. Neurosci. Res. 83, 702-709
51. Hoffman, W. H., Cheng, C., Passmore, G. G., Carroll, J. E., and Hess, D. (2002) Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci. Lett. 334, 71-74
52. Russell, R. R., 3rd, Cline, G. W., Guthrie, P. H., Goodwin, G. W., Shulman, G. I., and Taegtmeyer, H. (1997) Regulation of exogenous and endogenous glucose metabolism by insulin and acetoacetate in the isolated working rat heart.Athree tracer study of glycolysis, glycogen metabolism, and glucose oxidation. J. Clin. Invest. 100, 2892-2899
53. Pan, J. W., Bebin, E. M., Chu, W. J., and Hetherington, H. P. (1999) Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia 40, 703-707
54. Nordli, D. R., Jr., Kuroda, M. M., Carroll, J., Koenigsberger, D. Y., Hirsch, L. J., Bruner, H. J., Seidel, W. T., and De Vivo, D. C. (2001) Experience with the ketogenic diet in infants. Pediatrics 108, 129-133
55. Pauli, G., and Overath, P. (1972) ato Operon: a highly inducible system for acetoacetate and butyrate degradation in Escherichia coli. Eur. J. Biochem./FEBS 29, 553-562
56. Kyriakidis, D. A., and Tiligada, E. (2009) Signal transduction and adaptive regulation through bacterial two-component systems: the Escherichia coli AtoSC paradigm. Amino Acids 37, 443-458
57. Rosenblatt, J. D., Lunt, A. I., Parry, D. J., and Partridge, T. A. (1995) Culturing satellite cells from living single muscle fiber explants. In vitro Cell. Dev. Biol. Anim. 31, 773-779
58. Williamson, D. H., Bates, M. W., Page, M. A., and Krebs, H. A. (1971) Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem. J. 121, 41-47
59. Chen, Y., Ye, J., Cao, L., Zhang, Y., Xia, W., and Zhu, D. (2010) Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. Int. J. Biochem. Cell Biol. 42, 2072-2081
60. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and Rudnicki, M. A. (2000) Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786
61. Creuzet, S., Lescaudron, L., Li, Z., and Fontaine-Pérus, J. (1998) MyoD, myogenin, and desmin-nls-lacZ transgene emphasize the distinct patterns of satellite cell activation in growth and regeneration. Exp. Cell Res. 243, 241-253
62. Zammit, P. S. (2008) All muscle satellite cells are equal, but are some more equal than others? J. Cell Sci. 121, 2975-2982
63. Bogdanovich, S., Krag, T. O., Barton, E. R., Morris, L. D., Whittemore, L. A., Ahima, R. S., and Khurana, T. S. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421
64. Minetti, G. C., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V., Fortuni, S., Straino, S., Sampaolesi, M., Di Padova, M., Illi, B., Gallinari, P., Steinkühler, C., Capogrossi, M. C., Sartorelli, V., et al. (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 12, 1147-1150
65. Orii, K. E., Fukao, T., Song, X. Q., Mitchell, G. A., and Kondo, N. (2008) Liver-specific silencing of the human gene encoding succinyl-CoA:3-ketoacid CoA transferase. Tohoku J. Exp. Med. 215, 227-236
66. Fenselau, A., and Wallis, K. (1974) Substrate specificity and mechanism of action of acetoacetate coenzyme A transferase from rat heart. Biochemistry 13, 3884-3888
67. Fenselau, A., and Wallis, K. (1974) Ketone body usage by mammals. Acetoacetate substrate inhibition of CoA transferase from various rat tissues. Life Sci. 15, 811-818
68. Garedew, A., Andreassi, C., and Moncada, S. (2012) Mitochondrial dynamics, biogenesis, and function are coordinated with the cell cycle by APC/C CDH1. Cell Metab. 15, 466-479
69. Yang, W., Chen, Y., Zhang, Y., Wang, X., Yang, N., and Zhu, D. (2006) Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. Cancer Res. 66, 1320-1326
70. Wellen, K. E., and Thompson, C. B. (2012) A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13, 270-276
71. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R., and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
72. Freland, L., and Beaulieu, J. M. (2012) Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front. Mol. Neurosci. 5, 14
73. Laffel, L. (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 15, 412-426
74. Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G. W., Wolhuter, K., Stevens, M., Fischer, R., Carmeliet, P., Maxwell, P. H., Pugh, C. W., et al. (2011) Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524-537
75. Ooi, A., Wong, J. C., Petillo, D., Roossien, D., Perrier-Trudova, V., Whitten, D., Min, B. W., Tan, M. H., Zhang, Z., Yang, X. J., Zhou, M., Gardie, B., Molinié, V., Richard, S., Tan, P. H., et al. (2011) An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511-523
76. Jorquera, R., and Tanguay, R. M. (2001) Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability. Hum. Mol. Genet. 10, 1741-1752
77. Rous, S., and Favarger, P. (1973) The role of acetoacetate in the transfer of acetyl units outside the mitochondria in liver and adipose tissue of rats or mice. FEBS Lett. 37, 231-234
78. Rous, S., Bas, S., and Sengupta, S. (1980) Contribution of leucine in the fatty acid synthesis and ketogenesis in mice adipose tissue. Int. J. Biochem. 11, 337-340
79. Palmer, T. N., Gossain, S., and Sugden, M. C. (1993) Partial oxidation of leucine in skeletal muscle. Biochem. Mol. Biol. Int. 29, 255-262
80. Kornasio, R., Riederer, I., Butler-Browne, G., Mouly, V., Uni, Z., and Halevy, O. (2009)β-Hydroxy-β-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim. Biophys. Acta 1793, 755-763
81. Averous, J., Gabillard, J. C., Seiliez, I., and Dardevet, D. (2012) Leucine limitation regulates myf5 and myoD expression and inhibits myoblast differentiation. Exp. Cell Res. 318, 217-227
82. Areta, J. L., Hawley, J. A., Ye, J. M., Chan, M. H., and Coffey, V. G. (2014) Increasing leucine concentration stimulates mechanistic target of rapamycin signaling and cell growth in C2C12 skeletal muscle cells. Nutr. Res. 34, 1000-1007
83. Li, X., Gianoulis, T. A., Yip, K. Y., Gerstein, M., and Snyder, M. (2010) Extensive in vivo metabolite-protein interactions revealed by large-scale systematic analyses. Cell 143, 639-650
84. Li, X., and Snyder, M. (2011) Metabolites as global regulators: a new view of protein regulation: systematic investigation of metabolite-protein interactions may help bridge the gap between genome-wide association studies and small molecule screening studies. BioEssays 33, 485-489
85. Balasse, E. O., and Havel, R. J. (1971) Evidence for an effect of inulin on the peripheral utilization of ketone bodies in dogs. J. Clin. Invest. 50, 801-813
86. Cremer, J. E. (1971) Incorporation of label from D-β-hydroxy (14C)butyrate and (3-14C)acetoacetate into amino acids in rat brain in vivo. Biochem. J. 122, 135-138
87. Nakagawa, T., Ge, Q., Pawlosky, R., Wynn, R. M., Veech, R. L., and Uyeda, K. (2013) Metabolite regulation of nucleo-cytosolic trafficking of carbohydrate response element-binding protein (ChREBP): role of ketone bodies. J. Biol. Chem. 288, 28358-28367